Cite
HARVARD Citation
Rausch, C. et al. (2022). Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) – A case series. European journal of cancer. pp. 37-39. [Online].